In conclusion, a machine learning model trained with the key metagenome of IR can differentiate individuals with T2D from NGT with moderate accuracy on the basis of transcription profiles of adipose and other insulin-responsive tissues. This evidence concerns the gene INS and type 2 diabetes mellitus.